Moderna Seeks OK For Emergency Approval For COVID Vaccine, Now What?

The transcript discusses the progress of COVID-19 vaccines by Moderna and Pfizer, highlighting Moderna's 94% effectiveness in trials and the use of mRNA technology. Both vaccines are seeking emergency use authorization from the FDA, with hearings scheduled in December. Initial vaccine doses will be limited, with widespread availability expected by mid-next year. Public health measures remain crucial until vaccines are widely distributed. A CDC board will decide on vaccine prioritization.

What are the expected timelines for vaccine distribution to the American public?

What recommendations does the CDC Advisory Board plan to discuss regarding vaccine distribution?